# Q-Line Biotech released the subscription details for its initial public offering (IPO) Total subscription level reached 4.09 times the available shares.

*biotech · news · 2026-05-21 · scanx.trade*

## Key points

- Q-Line Biotech's IPO was oversubscribed 4.09 times overall across all investor categories.
- Non-Institutional Buyers (bHNI) subscribed 5.84 times their allocated shares, showing highest enthusiasm.
- Qualified Institutional Buyers (QIBs) subscribed 4.15 times, while retail investors subscribed 3.56 times.
- The Employee category showed no subscription, recording zero demand for the IPO allocation.

**Companies:** Q-Line Biotech
**Countries:** India

[Read the full story on scanx.trade](https://scanx.trade/stock-market-news/ipo/q-line-biotech-ipo-subscribed-4-09x-on-strong-demand/40916718)

---

Canonical: https://newsio.io/n/55675348-e60e-4274-a001-efb1ef04d78d/q-line-biotech-released-the-subscription-details-for-its-initial-public-offering
Summarized by Newsio from scanx.trade. https://newsio.io/how-it-works